Effects of rifampicin on the pharmacokinetics of alflutinib, a selective third-generation EGFR kinase inhibitor, and its metabolite AST5902 in healthy volunteers.
Invest New Drugs
; 39(4): 1011-1018, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33506323
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Pyrimidines
/
Rifampin
/
Protein Kinase Inhibitors
/
Cytochrome P-450 CYP3A Inducers
/
Indoles
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2021
Document type:
Article
Country of publication: